Corporate News tagged:

3D cell culture

REPROCELL Corporate News

Prof Stefan Przyborski to give Keynote Address at this year’s SMi 3D Cell Culture Conference

13 February 2020

REPROCELL’s Prof Stefan Przyborski to chair the SMi 2nd Annual Conference on 3D Cell Culture – London UK, 21-22 February 2018

24 January 2018

Formation of human tissue to improve drug testing and reduce animal research

19 January 2018

Scottish Enterprise Association Honours REPROCELL with Annual Awards Nomination

07 February 2017

Prof Stefan Przyborski to chair the SMi Group’s 3D Cell Culture 2017 Conference (22-23 Feb)

13 January 2017

REPROCELL Europe wins CV Technology Innovator Awards 2016 for Alvetex

16 September 2016

Prof Stefan Przyborski speaking at BBS 2016 Biennial Meeting

06 July 2016

REPROCELL Europe’s (formerly Reinnervate’s) CSO Prof Stefan Przyborski to give an Alvetex Seminar at the University of Oxford, 24 May 2016

20 May 2016

Reinnervate Ltd wins Corporate Vision’s 2015 Technology Innovator Award for Alvetex

22 March 2016

Alvetex in Space

14 January 2016

Publication of Paper on “3D culture model construction of mouse neurons” in Neuroscience Letters

18 November 2015

REPROCELL announces publication of a research report on “3D Skin Model Construction,” submitted to the International Scientific Journal “Molecular Cancer Therapeutics” by REPROCELL and others

19 October 2015

Alvetex® 3D cell culture platform reaches new heights with project aboard the International Space Station (ISS).

20 April 2015

Alvetex Scaffold 384 well plates used in an Oncology HTS program by AstraZeneca

08 October 2014

REPROCELL Acquires the iPS Cell Business Unit of Stemgent, Inc. (USA)

09 September 2014

Stem Cell Company REPROCELL (Japan) Acquires 3D Cell Culture Company Reinnervate (UK) and Human Tissue Supplier BioServe (USA)

05 August 2014

Launch of Reinnervate Perfusion System for 3D cell culture

05 February 2014

Reinnervate Ltd partners with Oncotest and SBH Sciences on introductory services for screening novel anti-cancer drugs using 3D tumour cell culture

04 November 2013

Reinnervate Ltd and Roslin Cellab to partner around 3D stem cell printing products and technologies

19 September 2013

Prof. Stefan Przyborski to participate at the XCellR8 Human Primary Cell Culture course, 7 November 2013

22 August 2013
1 2 Next 

Stem cell and drug discovery scientists around the world are using REPROCELL’s services and products in their preclinical and clinical research.

 About REPROCELL

Subscribe to receive updates

Corporate news by tag

  1. 3D cell culture
  2. Clinical capabilities
  3. Drug discovery
  4. Genomic services
  5. Human tissue samples
  6. Human tissue testing
  7. Life sciences
  8. Precision medicine
  9. Product Catalog
  10. Stem cells

 Corporate news archive